Structure-Based Design of Potential Anti-schistosomiasis Agent Targeting SmHDAC8: An In Silico Approach Utilizing QSAR, MD Simulation and ADMET Prediction-Reference-Cited by-同舟云学术

Structure-Based Design of Potential Anti-schistosomiasis Agent Targeting SmHDAC8: An In Silico Approach Utilizing QSAR, MD Simulation and ADMET Prediction

Published:2023-09-26 Issue: Volume: Page:
ISSN:2522-5758
Container-title:Chemistry Africa
language:en
Short-container-title:Chemistry Africa

Author:

Ja’afaru Saudatu Chinade^ORCID,Uzairu Adamu,Sallau Muhammed Sani,Ndukwe George Iloegbulam,Ibrahim Muhammad Tukur,Danazumi Ammar Usman

Publisher

Springer Science and Business Media LLC

Subject

Physical and Theoretical Chemistry,Environmental Chemistry,Chemistry (miscellaneous),Catalysis

Link

https://link.springer.com/content/pdf/10.1007/s42250-023-00777-2.pdf

Reference55 articles.

1. Barnett R (2018) Schistosomiasis. Lancet (London, England) 392(10163):2431

2. Mutapi F, Maizels R, Fenwick A, Woolhouse M (2017) Human schistosomiasis in the post mass drug administration era. Lancet Infect Dis 17(2):e42–e48

3. Faust CL, Osakunor DNM, Downs JA, Kayuni S, Stothard JR, Lamberton PHL et al (2020) Schistosomiasis control: leave no age group behind. Trends Parasitol 36(7):582–591

4. McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou XN (2018) Schistosomiasis. Nat Rev Dis Primers 4(1):13

5. Adenowo AF, Oyinloye BE, Ogunyinka BI, Kappo AP (2015) Impact of human schistosomiasis in sub-Saharan Africa. Braz J Infect Dis 19(2):196–205

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational modeling and molecular dynamics studies of methyl sulfonyl acetate derivatives as potent SmTGR inhibitors: insights into binding interactions;Molecular Simulation;2024-09-05

2. Exploring molecular interactions and ADMET profiles of novel MAO-B inhibitors: toward effective therapeutic strategies for neurodegenerative disorders;Future Journal of Pharmaceutical Sciences;2024-09-02

3. Unveiling potent inhibitors for schistosomiasis through ligand-based drug design, molecular docking, molecular dynamics simulations and pharmacokinetics predictions;PLOS ONE;2024-06-26

4. Exploring the potential of 2-arylbenzimidazole scaffolds as novel α-amylase inhibitors: QSAR, molecular docking, simulation and pharmacokinetic studies;In Silico Pharmacology;2024-04-11